Skip to content
Home page banner AIC (1)

The iCDP Summit is the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals.

Returning in 2020, the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit will help you to solve your challenges in this fast growing field, and to maximise the potential of the next-generation of cannabinoid pharmaceuticals.

Register your interest to receive agenda and speaker updates as they are announced.

Our 2019 Expert Speakers Included:

Guy Chamberland

Chief Executive Officer

Tetra Biopharma

Dennis Ahern

Vice President - Global Regulatory Affairs

Greenwich Biosciences

Mara Gordon

Founder & Director

Zelda Therapeutics

Dominic Chiapperino

Director of Controlled Substances Staff

U.S. Food and Drug Administration

Brian Murphy

Chief Executive Officer

Emerald Bioscience Inc.

Sara Ward

Researcher – Oncology

Temple University

Ethan Russo

Professor

International Cannabis and Cannabinoids Institute

Andrea Small-Howard

Chief Science Officer

GB Sciences

2019 Partners Included:

Lonza logo
Norm
ECS Logo
Avicanna_Logo1
Valeritas logo 2
PacerLogo-Final
CBD_logo
flack
Logo-colour 1